Dublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Chemiluminescence Immunoassay Analyzers - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global market for Chemiluminescence Immunoassay Analyzers was valued at US$6.5 Billion in 2024 and is projected to reach US$10.7 Billion by 2030, growing at a CAGR of 8.6% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The report includes the most recent global tariff developments and how they impact the Chemiluminescence Immunoassay Analyzers market.
What Factors Are Driving Growth in the Chemiluminescence Immunoassay Analyzers Market?
The growth in the chemiluminescence immunoassay analyzers market is driven by several factors, including technological advancements, the rising incidence of chronic and infectious diseases, and the growing demand for automation in clinical laboratories.
Technological advancements, such as enhanced automation, improved sensitivity, and the ability to perform multiplexed assays, are making CLIA analyzers more efficient and versatile, which in turn is driving their adoption across various diagnostic applications. The increasing prevalence of chronic conditions, such as cancer and autoimmune diseases, as well as the ongoing need for infectious disease testing, is fueling demand for accurate and reliable diagnostic tools like CLIA analyzers.
The trend towards automation in laboratories, aimed at reducing human error and increasing throughput, is also a significant driver, as CLIA systems offer the scalability and efficiency needed to handle high volumes of tests. Furthermore, the shift towards personalized medicine is expanding the use of biomarker-based diagnostics, where CLIA analyzers play a crucial role, further boosting market growth.
As healthcare providers and laboratories continue to seek ways to improve diagnostic accuracy and efficiency, the demand for advanced CLIA systems is expected to remain strong, supporting the sustained growth of this market.
Report Scope
The report analyzes the Chemiluminescence Immunoassay Analyzers market, presented in terms of units. The analysis covers the key segments outlined below.
Segments:
- Product Type (Reagents, Consumables, Analyzers)
- End-Use (Hospitals End-Use, Clinical Laboratories End-Use, Pharma & Biotech Companies End-Use, Other End-Uses)
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Reagents segment, which is expected to reach US$6.0 Billion by 2030 with a CAGR of a 10.7%. The Consumables segment is also set to grow at 5.9% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $1.8 Billion in 2024, and China, forecasted to grow at an impressive 12.4% CAGR to reach $2.3 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Agappe Diagnostics Ltd., Autobio Diagnostics Co., Ltd., Beckman Coulter, Inc., Beijing Hotgen Biotech Co., Ltd, Daan Gene Co., Ltd. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
What's Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free July 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 285 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $6.5 Billion |
| Forecasted Market Value (USD) by 2030 | $10.7 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Global Economic Update
- Chemiluminescence Immunoassay Analyzers - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
MARKET TRENDS & DRIVERS
- Advancements in Chemiluminescence Immunoassay Analyzers Propels Growth and Innovation
- Expanding Applications in Clinical Diagnostics Expands Addressable Market Opportunity
- Integration of AI and Machine Learning Strengthens the Business Case for Automated Chemiluminescence Systems
- Rising Prevalence of Chronic and Infectious Diseases Drives Adoption in Healthcare Settings
- Increasing Focus on Early Disease Detection Spurs Growth in Immunoassay Testing
- Emerging Markets in Developing Regions Generate New Growth Avenues
- Miniaturization and Portability of Analyzers Throw the Spotlight on Point-of-Care Testing
- Shift Towards Personalized Medicine Sustains Growth in Chemiluminescence Immunoassays
FOCUS ON SELECT PLAYERS
- Agappe Diagnostics Ltd.
- Autobio Diagnostics Co., Ltd.
- Beckman Coulter, Inc.
- Beijing Hotgen Biotech Co., Ltd
- Daan Gene Co., Ltd.
- DiaSorin SpA
- F. Hoffmann-La Roche AG
- Fujirebio, Inc.
- Genrui Biotech, Inc.
- QuidelOrtho Corporation
For more information about this report visit https://www.researchandmarkets.com/r/h13xwb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
